Trinity biotech announces the successful closing of its debt refinancing

Dublin, ireland, jan. 27, 2022 (globe newswire) -- trinity biotech plc (nasdaq: trib), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announced refinancing.

TRIB Ratings Summary

TRIB Quant Ranking